CIITA and cancer: Gene alterations occurring during cancer development can negatively regulate HLA expression [32, 33], for example damage to the class II transactivator (CIITA) gene, or large chromosomal deletions, as observed in diffuse large B cell lymphomas originating from immune-privileged sites [34].